Institutional shares held 105 Million
26.4K calls
19.2K puts
Total value of holdings $1.48B
$372K calls
$270K puts
Market Cap $2.18B
159,899,008 Shares Out.
Institutional ownership 65.71%
# of Institutions 238


Latest Institutional Activity in CERT

Top Purchases

Q4 2024
Principal Financial Group Inc Shares Held: 531K ($7.23M)
Q4 2024
Raymond James Financial Inc Shares Held: 341K ($4.64M)
Q4 2024
Edgestream Partners, L.P. Shares Held: 366K ($4.98M)
Q4 2024
Kopion Asset Management, LLC Shares Held: 556K ($7.56M)
Q4 2024
Vontobel Holding Ltd. Shares Held: 122K ($1.65M)

Top Sells

Q4 2024
Riverbridge Partners LLC Shares Held: 2.16M ($29.5M)
Q4 2024
Geneva Capital Management LLC Shares Held: 5.46M ($74.3M)
Q4 2024
Oppenheimer Asset Management Inc. Shares Held: 177K ($2.41M)
Q4 2024
Atria Investments LLC Shares Held: 14.2K ($193K)
Q4 2024
Illinois Municipal Retirement Fund Shares Held: 57.5K ($782K)

About CERT

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.


Insider Transactions at CERT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
335K Shares
From 18 Insiders
Grant, award, or other acquisition 108K shares
Exercise of conversion of derivative security 227K shares
Sell / Disposition
210K Shares
From 10 Insiders
Payment of exercise price or tax liability 122K shares
Open market or private sale 88.1K shares

Track Institutional and Insider Activities on CERT

Follow Certara, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERT shares.

Notify only if

Insider Trading

Get notified when an Certara, Inc. insider buys or sells CERT shares.

Notify only if

News

Receive news related to Certara, Inc.

Track Activities on CERT